Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.8M Sell
17,488
-3,141
-15% -$355K 0.06% 148
2025
Q4
$2.58M Buy
20,629
+2,656
+15% +$338K 0.07% 130
2025
Q3
$2.4M Sell
17,973
-4,000
-18% -$525K 0.07% 115
2025
Q2
$2.98M Sell
21,973
-1,070
-5% -$141K 0.1% 112
2025
Q1
$3.05M Sell
23,043
-380
-2% -$48.4K 0.13% 105
2024
Q4
$2.65M Buy
23,423
+542
+2% +$62.6K 0.02% 106
2024
Q3
$2.6M Sell
22,881
-6,784
-23% -$744K 0.11% 93
2024
Q2
$3.08M Sell
29,665
-59,687
-67% -$6.33M 0.16% 82
2024
Q1
$10.2M Buy
+89,352
New +$10.2M 0.47% 49

Other funds holding ABT

BNP Paribas's ABT Position: Q1 2026 in Review

BNP Paribas reduced its Abbott (ABT) stake by 15% in Q1 2026, selling an estimated $355K and leaving 17,488 shares worth $1.8M. The position accounts for 0.06% of the portfolio, ranked #148.

BNP Paribas first reported a position in ABT in Q1 2024 and has held it in 9 quarters since. The position peaked at $10.2M in Q1 2024. 3,083 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • BNP Paribas held 17,488 shares of Abbott worth $1.8M as of Q1 2026.
  • BNP Paribas sold 3,141 Abbott shares in Q1 2026, an estimated $355K.
  • Abbott made up 0.06% of BNP Paribas's portfolio in Q1 2026, its #148 holding.
  • BNP Paribas first reported a position in Abbott in Q1 2024 and has held it in 9 quarters since.
  • BNP Paribas's Abbott position peaked at $10.2M in Q1 2024.
  • 3,083 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on BNP Paribas's 13F filing for Q1 2026, filed 12 May 2026.